Showing results (61-70 of 87) with videos related to
Sort By:
Pageof 9
Molecular Cancer Therapeutics|January 27, 2016
Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple MyelomaAndrew Stiff, Enrico Caserta, Douglas W Sborov, et al.Cancer Cell|August 10, 2016
RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma DevelopmentFlavia Pichiorri, Sung-Suk Suh, Alberto Rocci, et al.Blood|January 6, 2018
Copper 64-labeled daratumumab as a PET/CT imaging tracer for multiple myelomaEnrico Caserta, Junie Chea, Megan Minnix, et al.Journal of Proteomics|January 18, 2016
Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markersSean W Harshman, Alessandro Canella, Paul D Ciarlariello, et al.Molecular Therapy Oncolytics|March 19, 2021
Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivoJayeeta Ghose, Ada Dona, Mariam Murtadha, et al.Journal of Hematology & Oncology|January 19, 2025
Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effectsAda Alice Dona, Theophilus Tandoh, Lokesh Nigam, et al.JCI Insight|October 9, 2019
MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophagesJihane Khalife, Jayeeta Ghose, Marianna Martella, et al.Leukemia|July 25, 2019
Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemiaHuafeng Wang, Dandan Zhao, Le Xuan Nguyen, et al.Leukemia|February 16, 2021
Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemiaLe Xuan Truong Nguyen, Bin Zhang, Dinh Hoa Hoang, et al.The Journal of Experimental Medicine|April 24, 2013
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulationFlavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.Pageof 9